Connect with us
Poland’s Ministry of Justice held a rare, lengthy meeting with Free Hemp activists to discuss decriminalizing cannabis, including a proposed 10-gram possession threshold via prosecutorial guidelines....
A December 2025 US executive order signals a major policy shift by treating medical cannabis as a public health issue rather than a tolerated exception. It...
Agential Cannabis 2026, Asia-Pacific’s premier medical cannabis trade fair and conference, will be held on September 23–24 at Bangkok’s BITEC. Bringing together industry leaders, regulators, and...
In 2025 Poland, legal medical cannabis has clear quality, safety, and dosing advantages over unpredictable illegal street product, making therapeutic use more sensible than recreational smoking....
In 2025, medical cannabis use in Poland stabilized and matured. Pharmacies dispensed over 5 tons to 105,000 patients through 537,000 prescriptions. Growth slowed after rapid expansion...
Europe’s cannabis reputation often points to the Netherlands or Portugal, yet Malta and Luxembourg made the real breakthrough by granting a legal right to home cultivation....
On December 15, 2025, President Trump confirmed his administration is strongly considering reclassifyingcannabis from Schedule I to Schedule III. While not full legalization, the shift would...
The German cannabis industry faces regulatory and competitive turmoil. Remexian is accused by competitor Vayamed of violating licensing rules for irradiated medicinal cannabis by using group...
Seven years after legalization, Canada has collected over CAD 5.4 billion in cannabis taxes, mostly benefiting provinces—Alberta leads per capita, while Quebec lags due to restrictive...
The Swiss Hemp Association welcomes Switzerland’s draft Cannabis Act as a historic shift toward regulated, science-based legalization but urges key improvements. It argues Switzerland can outperform...